Jean Emond

Q: What Schools Are Affiliated With Jean Emond

Jean Emond is affiliated with the following schools: University of Chicago, University of California, San Francisco, Columbia University, University of Pennsylvania

Jean Emond's AcademicInfluence.com Rankings

Jean Emond

Philosophy

#8845

World Rank

#12302

Historical Rank

#1729

USA Rank

Logic

#5858

World Rank

#7303

Historical Rank

#912

USA Rank

philosophy Degrees

Download Badge

Philosophy

Jean Emond's Degrees

Doctorate Medicine University of Pennsylvania
PhD Immunology University of Pennsylvania

Why Is Jean Emond Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jean C. Emond is the current Thomas S. Zimmer Professor of Surgery at the Columbia University College of Physicians & Surgeons. He is also a Vice Chair in the Department of Surgery and the Chief of Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Emond completed both his undergraduate and medical training at the University of Chicago.

(See a Problem?)

Jean Emond's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors (2010) (793)
Liver transplantation in children from living related donors. Surgical techniques and results. (1991) (666)
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter (2020) (652)
Application of Reduced‐size Liver Transplants as Split Grafts, Auxiliary Orthotopic Grafts, and Living Related Segmental Transplants (1990) (579)
Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series (2010) (486)
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. (2012) (448)
Donor morbidity after living donation for liver transplantation. (2008) (380)
The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors (1995) (380)
Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation (2008) (374)
Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma (2009) (364)
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. (1996) (354)
Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor (2002) (340)
Outcomes of 385 Adult-to-Adult Living Donor Liver Transplant Recipients: A Report From the A2ALL Consortium (2005) (325)
New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens (1983) (281)
Transplantation of Two Patients with One Liver: Analysis of a Preliminary Experience with 'Split‐liver' Grafting (1990) (274)
Hypothermic Machine Preservation Facilitates Successful Transplantation of “Orphan” Extended Criteria Donor Livers (2015) (263)
Ethics of liver transplantation with living donors. (1989) (252)
Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort Study† (2008) (246)
Utilization of Extended Donor Criteria Liver Allografts Maximizes Donor Use and Patient Access to Liver Transplantation (2005) (194)
Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story (2017) (189)
Model for end‐stage liver disease and Child‐Turcotte‐Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients (2002) (186)
LIVER TRANSPLANTATION WITH REDUCED‐SIZE DONOR ORGANS (1988) (181)
Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. (1991) (179)
Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. (1997) (178)
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice (2004) (176)
Steatohepatitic Hepatocellular Carcinoma (SH-HCC): A Distinctive Histological Variant of HCC in Hepatitis C Virus-related Cirrhosis With Associated NAFLD/NASH (2010) (173)
Liver Transplantation, Including the Concept of Reduced‐size Liver Transplants in Children (1988) (169)
The Impact of Pre‐Operative Loco‐Regional Therapy on Outcome After Liver Transplantation for Hepatocellular Carcinoma (2005) (168)
Reconstruction of the hepatic vein in reduced size hepatic transplantation. (1993) (167)
Liver transplantation for sclerosing cholangitis (1995) (166)
Managing the Prevention of Retained Surgical Instruments: What Is the Value of Counting? (2008) (155)
HEPATIC ARTERY THROMBOSIS IN INFANTS A COMPARISON OF WHOLE LIVERS, REDUCED‐SIZE GRAFTS, AND GRAFTS FROM LIVING‐RELATED DONORS 1 (1992) (146)
Improved results of living-related liver transplantation with routine application in a pediatric program. (1993) (145)
Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress (2007) (144)
Split-Liver Transplantation in the United States: Outcomes of a National Survey (2004) (144)
Liver transplantation in the management of fulminant hepatic failure. (1989) (136)
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB (2005) (136)
Reduced‐size orthotopic liver transplantation: Use in the management of children with chronic liver disease (1989) (134)
Hypothermic Machine Preservation Reduces Molecular Markers of Ischemia/Reperfusion Injury in Human Liver Transplantation (2012) (134)
BILIARY COMPLICATIONS IN PEDIATRIC LIVER TRANSPLANTATION A COMPARISON OF REDUCED‐SIZE AND WHOLE GRAFTS 1 (1992) (133)
Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). (1995) (131)
Incidence and Severity of Acute Cellular Rejection in Recipients Undergoing Adult Living Donor or Deceased Donor Liver Transplantation ‡ (2009) (126)
Liver transplantation for fulminant hepatic failure. (1993) (126)
Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors (2003) (125)
Utility of operative ultrasound in the surgical management of liver tumors. (1986) (119)
Liver transplantation for hepatoblastoma. The American experience. (1991) (117)
Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. (1999) (114)
Defining long-term outcomes with living donor liver transplantation in North America. (2015) (113)
Right Heart Dysfunction, Pulmonary Embolism, and Paradoxical Embolization during Liver Transplantation: A Transesophageal Two‐Dimensional Echocardiographic Study (1989) (112)
Split‐Liver Transplantation: A Review (2003) (107)
Organ donation and utilization in the USA (2004) (104)
Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment (2014) (104)
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1 (1993) (102)
Extended-donor criteria liver allografts. (2006) (100)
Liver transplantation for hepatitis C virus‐related cirrhosis (1994) (99)
Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. (2011) (94)
Totally Laparoscopic Full Left Hepatectomy for Living Donor Liver Transplantation in Adolescents and Adults (2013) (93)
Successful hepatic transplantation in congenital absence of recipient portal vein. (1990) (93)
Liver transplantation for the treatment of urea cycle disorders (1998) (93)
Small-bowel length and the dose of cyclosporine in children after liver transplantation. (1990) (92)
Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. (2012) (91)
Protection of the liver during hepatic surgery (2004) (91)
Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. (2011) (89)
Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002 (2008) (87)
Incidence and significance of Aspergillus cultures following liver and kidney transplantation. (1996) (87)
Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe (2015) (84)
Outcomes of adult living donor liver transplantation: Comparison of the adult‐to‐adult living donor liver transplantation cohort study and the national experience (2011) (82)
Anesthetic considerations during liver surgery. (2004) (82)
Outcomes of living donor liver transplantation for acute liver failure: The adult‐to‐adult living donor liver transplantation cohort study (2008) (81)
Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. (1990) (80)
Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon‐Palais Des Congrès (2006) (79)
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. (2009) (77)
The use of the T tube after orthotopic liver transplantation. (1996) (76)
Optimizing the use of donated cadaver livers: Analysis and policy development to increase the application of split‐liver transplantation (2002) (76)
Failure patterns of cryopreserved vein grafts in liver transplantation. (1996) (76)
Donor selection limits use of living‐related liver transplantation (1995) (75)
Global Transplantation COVID Report March 2020 (2020) (72)
Analysis of Failure in Living Donor Liver Transplantation: Differential Outcomes in Children and Adults (2003) (70)
Fully laparoscopic left‐sided donor hepatectomy is safe and associated with shorter hospital stay and earlier return to work: A comparative study (2015) (70)
COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation. (2020) (69)
Liver regeneration after living donor transplantation: Adult‐to‐adult living donor liver transplantation cohort study (2015) (69)
Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. (1995) (67)
Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation (2012) (66)
Blockade of the receptor for advanced glycation end products attenuates acetaminophen‐induced hepatotoxicity in mice (2006) (66)
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies (2018) (66)
Surgical Anatomy of the Left Lateral Segment as Applied to Living-Donor and Split-Liver Transplantation: A Clinicopathologic Study (2000) (66)
Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. (1995) (64)
Donor Health Assessment After Living-Donor Liver Transplantation (2002) (64)
Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. (1984) (62)
Predictors of the cost of liver transplantation. (1998) (60)
Impact of Adult Living Donor Liver Transplantation on Waiting Time Survival in Candidates Listed for Liver Transplantation (2004) (60)
Biliary complications of reduced-organ liver transplantation. (1998) (60)
Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity. (2006) (59)
The impact of surgical complications after liver transplantation on resource utilization. (1997) (58)
Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience (2016) (57)
Predicting early allograft failure and mortality after liver transplantation: The role of the postoperative model for end‐stage liver disease score (2013) (56)
Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation (2008) (53)
One‐year morbidity after donor right hepatectomy (2004) (51)
Vasopressin deficiency and vasodilatory state in end-stage liver disease. (2011) (50)
Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. (2014) (49)
Critical care of the end‐stage liver disease patient awaiting liver transplantation (2011) (49)
Risk factors and outcomes of carbapenem‐resistant Klebsiella pneumoniae infections in liver transplant recipients (2015) (48)
COMBINED TREATMENT WITH LHRH AGONIST AND PURE ANTIANDROGEN IN ADVANCED CARCINOMA OF PROSTATE (1984) (48)
The ethical assessment of innovative therapies: Liver transplantation using living donors (1990) (47)
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma (2018) (47)
Outflow reconstruction in right hepatic live donor liver transplantation. (2003) (45)
Posttransplantation growth in pediatric liver recipients (2001) (45)
Expanding the Margins: High Volume Utilization of Marginal Liver Grafts Among >2000 Liver Transplants at a Single Institution (2017) (45)
Addition of adult‐to‐adult living donation to liver transplant programs improves survival but at an increased cost (2009) (44)
Liver transplants from living related donors. (2001) (43)
Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. (1997) (43)
Decreased mortality from technical failure improves results in pediatric liver transplantation. (1996) (42)
Patterns of infection after pediatric liver transplantation. (1992) (42)
Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD (2015) (42)
No country for old livers? Examining and optimizing the utilization of elderly liver grafts (2018) (40)
Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection (2021) (40)
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study (2020) (40)
Leaning to the Left: Increasing the Donor Pool by Using the Left Lobe, Outcomes of the Largest Single-center North American Experience of Left Lobe Adult-to-adult Living Donor Liver Transplantation (2016) (39)
Surgical and anesthetic management of patients undergoing major hepatectomy using total vascular exclusion. (1996) (39)
Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients (2014) (38)
Hepatic oxygen and lactate extraction during stagnant hypoxia. (1991) (38)
Pure Laparoscopic Donor Hepatectomies: Ready for Widespread Adoption? (2018) (38)
Select Utilization of Obese Donors in Living Donor Liver Transplantation: Implications for the Donor Pool (2005) (38)
Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL‐2) (2017) (37)
Analysis of Donor Risk in Living‐Donor Hepatectomy: The Impact of Resection Type on Clinical Outcome (2002) (37)
Ethics of liver transplantation with living donors (1990) (36)
Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience (2013) (36)
Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. (1999) (36)
The successful management of portal vein thrombosis after hepatic transplantation with a splenorenal shunt. (1988) (35)
Molecular expression of acute phase mediators is attenuated by machine preservation in human liver transplantation: preliminary analysis of effluent, serum, and liver biopsies. (2011) (35)
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues (2013) (35)
Microvascular hepatic artery anastomosis in pediatric segmental liver transplantation: microscope vs loupe (2002) (35)
Hepatic arterial anatomy as applied to living‐donor and split‐liver transplantation (2000) (35)
Opposing roles of RAGE and Myd88 signaling in extensive liver resection (2012) (34)
Multivisceral Ex Vivo Surgery for Tumors Involving Celiac and Superior Mesenteric Arteries (2012) (34)
Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (2016) (34)
Evolution and future perspectives for reduced-size hepatic transplantation. (1990) (34)
Surgical anatomy of the liver and its application to hepatobiliary surgery and transplantation. (1994) (33)
Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. (2002) (33)
Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors (2003) (32)
Experience with aggressive therapy in three children with unresectable malignant liver tumors. (2000) (32)
Timing of liver transplantation in biliary atresia-results in 71 children managed by a multidisciplinary team. (2008) (31)
Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation (2014) (31)
Biliary anatomy as applied to pediatric living donor and split‐liver transplantation (2000) (31)
34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 1 (2019) (30)
Outcomes of COVID‐19 in solid organ transplant recipients: A matched cohort study (2021) (30)
Increased immune responses to regenerating partial liver grafts in the rat. (1997) (29)
Basiliximab Induction and Delayed Calcineurin Inhibitor Initiation in Liver Transplant Recipients With Renal Insufficiency (2011) (29)
Fifty-percent partial liver transplantation in the rat. (1996) (28)
Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult‐to‐adult living donor liver transplantation cohort study experience (2017) (27)
OKT3 THERAPY FOR HEPATIC ALLOGRAFT REJECTION: DIFFERENTIAL RESPONSE IN ADULTS AND CHILDREN (1991) (26)
The deceased organ donor with an “open abdomen”: proceed with caution (2012) (26)
Safety of Blood Group A2-to-O Liver Transplantation: An Analysis of the United Network of Organ Sharing Database (2012) (26)
Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience (2017) (25)
Obesity and Microvascular Invasion in Hepatocellular Carcinoma (2010) (25)
Rejection in Liver Allograft Recipients: Clinical Characterization and Management (1987) (24)
Posttransplant Lymphoproliferative Disorder Presenting in the Head and Neck (1997) (24)
The Impact of Hepatitis C and Biliary Complications on Patient and Graft Survival Following Liver Transplantation (2009) (23)
Changes in hepatic venous morphology with cirrhosis on MRI (2009) (23)
Liver Transplantation for Hepatoblastoma (1991) (23)
RAGE Signaling Significantly Impacts Tumorigenesis and Hepatic Tumor Growth in Murine Models of Colorectal Carcinoma (2010) (23)
Auxiliary liver transplant in fulminant failure. (1997) (22)
Hepatitis C-associated granulomas after liver transplantation: morphologic spectrum and clinical implications. (2007) (21)
A Critical Evaluation of Hepatic Resection in Cirrhosis: Optimizing Patient Selection and Outcomes (2005) (21)
Pediatric orthotopic liver transplantation: multifactorial predictions of blood loss. (1986) (20)
Longterm outcomes of auxiliary partial orthotopic liver transplantation in preadolescent children with fulminant hepatic failure (2016) (20)
Overview of reduced-size liver transplantation. (1991) (19)
Living donor liver transplantation and hepatitis C. (2003) (19)
Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience (1990) (19)
Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients (2015) (19)
Ruptured mature cystic teratoma of the ovary with recurrence in the liver and colon 17 years later. A case report. (1990) (19)
Resource Utilization of Living Donor Versus Deceased Donor Liver Transplantation Is Similar at an Experienced Transplant Center (2009) (19)
Changes in liver and spleen volumes after living liver donation: A report from the adult‐to‐adult living donor liver transplantation cohort study (A2ALL) (2015) (19)
Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West–East Collaborative Effort (2020) (18)
Anesthetic implications of extended right hepatectomy in a patient with fontan physiology. (2014) (18)
Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels (2020) (18)
[Genotyping of 21,000 blood donors in Quebec and RHD analysis]. (2010) (18)
Effect of massive transfusion during liver transplantation on rejection and infection. (1988) (18)
Deceased Brain Dead Donor Liver Transplantation and Utilization in the United States: Nighttime and Weekend Effects. (2019) (18)
47 – Outcomes of Living Donor Liver Transplantation (2005) (17)
Early Graft Dysfunction in Living Donor Liver Transplantation and the Small-for-size Syndrome (2014) (16)
Immune Cell Trafficking to the Liver. (2019) (16)
Anesthetic management of combined heart-liver transplantation. (2007) (16)
Pediatric liver transplantation at the University of Chicago Hospitals. (1992) (16)
Complex Hepatectomy under Total Vascular Exclusion of the Liver: Impact of Ischemic Preconditioning on Clinical Outcomes (2013) (15)
Planned exploration of pediatric liver transplant recipients reduces posttransplant morbidity and lowers length of hospitalization. (1997) (15)
Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant. (2021) (15)
Segmental Liver Transplantation From Living Donors Report of the Technique and Preliminary Results in Dogs (1990) (15)
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma. (2021) (15)
Orthotopic partial liver transplantation in the rat: a model of 70% hepatectomy and reduced size liver transplantation. (1993) (14)
Anatomical hepatectomy for resection or transplantation. (1996) (14)
Liver transplantation for controversial indications: alcoholic liver disease, hepatic cancers, and viral hepatitis. (1991) (14)
Primary follicular lymphoma of the extrahepatic bile duct mimicking a hilar cholangiocarcinoma: case report and review of the literature. (2009) (14)
Early gene expression associated with regeneration is intact after massive hepatectomy in rats. (1998) (14)
Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody–positive donors (2012) (14)
Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins. (1988) (14)
Increased utilization of organ donors: transplantation of two recipients from single donor livers. (1990) (13)
Cystic duct remnant mucocele in a liver transplant recipient. (1994) (13)
Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and in the postoperative period: A cause for concern (2014) (13)
The living-related liver transplant evaluation: linking risk factors and outcome. (1996) (13)
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children (2018) (12)
Liver atrophy and regeneration in noncirrhotic portal vein thrombosis: Effect of surgical shunts (2018) (12)
Serum lipid expression correlates with function and regeneration following living donor liver transplantation (2016) (12)
Developments in segmental and living related liver transplantation. (1992) (12)
Predictors of Candidate Maturation Among Potential Living Donors (2005) (12)
Advances in segmental liver transplantation: can we solve the donor shortage? (2001) (12)
COMBINATION THERAPY IN PROSTATE CANCER (1986) (12)
Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma (2015) (12)
Severe pulmonary hypertension due to chronic echinococcal pulmonary emboli treated with targeted pulmonary vascular therapy and hepatic resection. (2007) (12)
Anatomic features of reduced-size liver transplant: postsurgical imaging characteristics. (1993) (11)
Computerized assessment of competence‐related abilities in living liver donors: the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study (2013) (11)
Center-related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization (2020) (11)
Early Kidney Allograft Failure After Simultaneous Liver-kidney Transplantation (SLKT): Evidence for Utilization of the Safety Net? (2020) (11)
Acute lymphoblastic leukemia at relapse in a child with acute myeloblastic leukemia. (1986) (11)
Innovative use of organs for liver transplantation. (1991) (11)
Prevalence of high‐risk human papilloma virus among women with hepatitis C virus before liver transplantation (2013) (11)
Ex vivo pancreaticoduodenectomy and liver autotransplantation for pancreatic head tumor with extensive involvement of the hepatoduodenal ligament (2015) (10)
Living donor liver transplantation and hepatitis C (2004) (10)
Multicenter review of liver transplant for hepatitis B‐related liver disease: disparities in gender and ethnicity (2013) (10)
Utilization of Hepatitis C Virus (HCV)‐Viremic Organs for HCV Negative Recipients: Is Practice Speeding Past the Evidence? (2020) (10)
Smoking and hepatocellular carcinoma mortality. (2012) (10)
COMBINED TREATMENT WITH FLUTAMIDE AND SURGICAL OR MEDICAL (LHRH AGONIST) CASTRATION IN METASTATIC PROSTATIC CANCER (1986) (10)
Ex Vivo Resection and Autotransplantation for Conventionally Unresectable Tumors - An 11-year Single Center Experience. (2020) (10)
Management of liver metastases: new horizons for biologically based therapy. (2004) (9)
Interpretation of Liver Chemistries in Adult Donors After Living Donor Liver Transplantation (2004) (9)
Prior esophageal variceal bleeding does not adversely affect survival after orthotopic liver transplantation (1993) (9)
Transplant Surgery Pipeline: A Report from the American Society of Transplant Surgeons Pipeline Taskforce. (2021) (9)
Indications for liver transplantation in pediatric patients. (1991) (9)
Other clinical studyLiver transplantation for sclerosing cholangitis (1995) (9)
A Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome—Review of the Literature (2017) (9)
Functional distal splenorenal shunt and splenic artery ligation as portal flow modulation in left lobe living donor transplantation (2014) (8)
Retrospective‐prospective study of safety and efficacy of sofosbuvir‐based direct‐acting antivirals in HIV/HCV‐coinfected participants with decompensated liver disease pre– or post–liver transplant (2020) (8)
Measuring access to liver transplantation: An overdue metric for center quality and performance. (2016) (8)
Living-Donor Liver Transplantation: Current Perspective (2012) (8)
A liver for a kidney: Ethics of trans‐organ paired exchange (2018) (8)
DELAYED REJECTION OF HEART ALLOGRAFTS IN HYPERSENSITIZED RATS BY EXTRACORPOREAL DONOR‐SPECIFIC LIVER HEMOPERFUSION (1986) (8)
Splenic arteriovenous fistula (1996) (7)
Living Donor Liver Transplantation in Children What to Recommend? (2004) (7)
What's new in transplantation. (2002) (7)
Process of Care Events in Transplantation: Effects on the Cost of Hospitalization (2010) (7)
Nivolumab for hepatocellular carcinoma (HCC) in a real-world context. (2019) (7)
Living related donor liver transplantation: the UCSF experience. (1996) (7)
Clinical application of liver-related liver transplantation. (1993) (6)
Physiology and Anatomy of the Liver (2012) (6)
Hepatic venous reconstruction as the stake of the liver: Technical note and thoughts (2014) (6)
Use of cryopreserved vein allogeneic homografts in liver transplantation. (1993) (6)
9 Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors (2003) (6)
Digital imaging of extended criteria donor livers to facilitate placement and utilization. (2010) (6)
Adherence to hepatitis B immunoglobulin (HBIG) after liver transplantation. (2013) (5)
Living related liver transplantations (1992) (5)
Experience With Radical Resection in The Management of Proximal Bile Duct Cancer (1989) (5)
Managing access to liver transplantation: implications for gastroenterology practice. (2007) (5)
Strategies for tolerance induction: potential applications in living donor liver transplantation. (1996) (5)
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. (2022) (5)
OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children. (1990) (5)
Use of an absorbable suture material in vascular anastomoses in pediatric liver transplantation. (1993) (5)
Liver transplantation at the University of California, San Francisco. (1993) (4)
DONOR HEALTH ASSESSMENT FOLLOWING LIVING‐DONOR LIVER TRANSPLANTATION.: Abstract# 689 (2000) (4)
Tolerance in clinical liver transplantation: The long road ahead (2017) (4)
Whose Liver Is It Anyway? Two Centers Participating in One Living Donor Transplantation (2019) (4)
The art of deduction (1986) (4)
Reducing Complications in Pediatric Liver Transplantation: Do We Have the Answer? (2012) (4)
[Orthotopic liver transplantation and living donors. An experimental study in the dog]. (1990) (4)
Exploring Medical Students' Perceptions of Organ Procurement: Need for a Formalized Medical Student Curriculum. (2019) (4)
Discovery of diffuse biliary microhamartomas during liver procurement (2007) (4)
Isolated liver transplantation for decompensated end-stage liver disease in children with intestinal failure. (2006) (4)
Prognostic factors and management of carcinomas of the gallbladder and extrahepatic bile ducts. (1997) (4)
TRANSESOPHAGEAL ECHOCARDIOGRAPHY DURING LIVER TRANSPLANTATION (1987) (3)
Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody–positive donors (2013) (3)
Improved technique of 70% hepatectomy in dogs. (1993) (3)
Ex-vivo tumor resection and auto-transplantation: A single-institutional long-term experience. (2017) (3)
Transplantation in value‐based care for patients with renal failure (2018) (3)
Laparoscopic Donor Hepatectomy: A Way Forward? (2017) (3)
Morphine three‐dimensional T1 gadoxetate MR cholangiography of potential living related liver donors (2014) (3)
Growth of liver allografts over time in pediatric transplant recipients (2018) (3)
Living Donor Liver Transplantation in emergencies: Is it time to say yes? (2015) (3)
Early disappearance of donor-specific immunofluorescence in spontaneously tolerated liver allografts in inbred rats. (1987) (3)
An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard. (2014) (3)
MECHANISM OF MYOCARDIAL DYSFUNCTION DURING LIVER TRANSPLANTATIONTHE ROLE OF ISOLATED RIGHT VENTRICULAR FAILURE (1987) (2)
The Importance of Bringing Transplantation Tolerance to the Clinic. (2021) (2)
2 – Surgical Anatomy of the Liver (2005) (2)
Reduced-Size Liver Transplantation (1990) (2)
Pregnancy Outcomes in Women with Autoimmune Hepatitis – a Nationwide Population-Based Cohort Study with Histopathology (2021) (2)
The effects of hyperperfusion in the isolated perfused rat liver (1995) (2)
Big improvements for the smallest recipients (2017) (2)
Transplantation of hepatic segments (1988) (2)
Hypothermic Machine Preservation and Transplantation of “Orphan” Extended Criteria Donor Livers.: Abstract# 2116 (2014) (2)
Donor Evaluation, Surgical Technique and Perioperative Management (2009) (2)
Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience (2004) (2)
Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation. (1988) (2)
Digital Imaging of Extended Criteria Donor Livers to Facilitate Placement and Utilization (2010) (2)
Combined Liver-Lung-Kidney Transplant in a Patient with Cystic Fibrosis (2021) (1)
[Preservation of donor livers with University of Wisconsin solution]. (1991) (1)
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma (2022) (1)
Combined Treatment with an LHRH Agonist and the Antiandrogen Flutamide in Prostate Cancer (1986) (1)
[Size reduction of the donor liver before orthotopic transplantation. Surgical technic and results]. (1988) (1)
Autologous Stem Cell Transplant to Treat Recurrent Primary Sclerosing Cholangitis: Tolerance, but at What Price? (2021) (1)
Discarding Livers From Deceased Donors: Is It Ever OK? (2020) (1)
Delayed Gastric Emptying after Living Donor Hepatectomy for Liver Transplantation (2014) (1)
Living related liver transplantation: request for an international ethics consultation from the Research Center for Surgery in Moscow. (1994) (1)
Anatomical variations encountered in living-donor and split-liver transplantation (2000) (1)
Is it Still Tough to Make Predictions About the Future? (2019) (1)
[Splitting liver transplantation. Orthotopic liver transplantation in two recipients with a single donor liver]. (1991) (1)
Liver transplantation in children: advances in patient selection, technique and immunosuppression. (1997) (1)
The concept of reduced-size liver transplantation, including split-liver and living related liver transplantation (1991) (1)
International Perspectives on Advanced Liver Surgery (2013) (1)
Phase I trial of sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation (LT). (2011) (1)
Serious Adverse Drug Reactions Related to Boceprevir: Analysis of Food and Drug Administration Reported Events (2013) (1)
COVID-19: a year on. (2020) (1)
Acute Myocardial Failure After Liver Transplantation: Tako-Tsubo or Undiagnosed Cirrhotic Cardiomyopathy?: Abstract# D2626 (2014) (1)
Long Term Outcomes of Auxiliary Partial Orthotopic Liver Transplantation in Pre-Teenage Children With Fulminant Hepatic Failure.: Abstract# D2585 (2014) (1)
1028 Treatment of acute cellular rejection with high-dose steroids, but not modulation of baseline immunosuppression, is associated with severe HCV recurrence in both living and deceased donor liver transplant recipients (2003) (1)
Management of biliary anastomotic strictures complicating liver transplantation (1997) (1)
HYPOTHERMIC MACHINE PERFUSION OF LIVER GRAFTS FOR TRANSPLANTATION: ASSESSMENT AND DEVELOPMENT IN HUMAN DISCARD AND MINIATURE SWINE MODELS (2004) (1)
Immediate Post-Reperfusion PBL Activation Associated With Liver Early Allograft Dysfunction (EAD).: Abstract# 1332 (2014) (0)
Reply: To PMID 24954365. (2015) (0)
IMPORTANCE OF EMPOWERING PEDIATRICIANS IN THE OUTPATIENT CARE OF CHILDREN WITH LIVER TRANSPLANTS. † 492 (1997) (0)
Statins are associated with a decreased risk of severe liver disease in individuals with non-cirrhotic chronic liver disease. (2023) (0)
Chapter 38 – The Transplant Operation: What the Hepatologist Should Know (2006) (0)
Lymphoproliferative disorders after liver transplantation (OLT): a recent experience (1991) (0)
Heroic measures with extensive vascular reconstructions for intrahepatic cholangiocarcinoma provides acceptable oncologic outcomes (2020) (0)
LAMIVUDINE MONOTHERAPY PREVENTS DE NOVO HEPATITIS B IN RECIPIENTS OF HBCAB (+) GRAFTS: A RETROSPECTIVE ANALYSIS. (2006) (0)
[Double cell population in dizygotic twins. Immunologic and cytogenetic data]. (1970) (0)
Medical Castration with LHRH Agonists and the Need for Combined Treatment with an Antiandrogen in Prostate Cancer (1984) (0)
Combination Therapy with the Antiandrogen Flutamide and the LHRH Agonist [D-Trp 6 , des-Gly-NH 2 10 ]LHRH Ethylamide in Prostate Cancer: Rationale and 5-Year Clinical Experience (1988) (0)
4:21 PM Abstract No. 236 Survival outcomes of elderly patients with hepatocellular carcinoma treated with loco-regional therapy: a 20-year single-center experience (2020) (0)
S-I-3 Surgical Problems in Pediatric Liver Transplantation (1992) (0)
Split livers and live donors : application and techniques (1991) (0)
59 – Postoperative Care of Pediatric Liver Transplant Recipients (2005) (0)
360.7: Ex vivo tumor resection and intestinal autotransplantation – a single center 10-year experience (2019) (0)
A Single-Center Retrospective Review of 119 Liver Transplants With Hepatitis B Core Antibody Positive (HBcAb+) Grafts in Surface Antigen Negative (HBsAg-) Recipients (2011) (0)
Commentary on: Temporary portal vein embolization is as efficient as permanent portal vein embolization in mice. (2017) (0)
Reply: Hepatology, Vol. 00, No. X, 2014 CORRESPONDENCE (2015) (0)
Hepatitis C — related granulomas occurring post orthotopic liver transplants (OLTX) are associated with poor clinical outcomes (2002) (0)
Serum folate, LINE-1 hypomethylation, and overall survival in a prospective cohort of hepatocellular carcinoma patients. (2012) (0)
Effect of RAGE signaling on colorectal liver metastases (2007) (0)
PER ORAL CHOLANGIOSCOPY (POCS) IN LIVER TRANSPLANT PATIENTS: A PROSPECTIVE, INTERNATIONAL SERIES (2022) (0)
Reduced-size liver transplantation. Hope for pediatric patient with end-stage liver disease. (1990) (0)
Orthotope Segmentale Lebertransplantation beim Kind (1988) (0)
I% the M .lure Iana gement (1989) (0)
Correlating Liver and Kidney Donor Risk Index (DRI) With Gene Expression in the Organ Biopsy Prior to Reperfusion.: Abstract# A500 (2014) (0)
Continuous Measurement of Portal Vein Pressure in Porcine Liver Resection Model Using a Wireless Telemetric Method - A Useful Tool?: Abstract# C1934 (2014) (0)
EXPANDED CRITERIA DONOR LIVER UTILIZATION: WHO AND WHEN? (2006) (0)
Transplant vs resection for intrahepatic cholangiocarcinoma- potential for benefit with transplant? (2020) (0)
Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference. (2023) (0)
Development and Validation of an Artificial Intelligence Model for a Better Prediction of Hepatocellular Cancer Recurrence after Transplantation: A Retrospective International Study (2022) (0)
Reply (2015) (0)
Response to pre-op chemotherapy may be important in success of liver transplantation for hepatic tumors in children (1998) (0)
Subject Index Vol. 25, 1993 (1993) (0)
Current Perspectives on LDLT (2014) (0)
EFFECTS OF CRYOPRESERVATION ON IN VITRO AND IN VIVO LONG-TERM FUNCTION OF HUMAN ISLETS 1 (1999) (0)
Disparities in hepatopancreatobiliary operative experience among general surgery residents: a 27-year analysis of ACGME case logs (2018) (0)
Pregnancy outcomes in women with autoimmune hepatitis - A nationwide population-based cohort study with histopathology. (2021) (0)
CLINICAL CHARACTERIZATION OF REJECTION IN HUMAN ORTHOTOPIC LIVER-TRANSPLANTATION (1986) (0)
Expression of early response genes after massive hepatectomy in rats (1995) (0)
Novel Noninvasive Biomarkers in Liver Transplantation: A Tool on the Doorstep of Clinical Utilization. (2023) (0)
[Transplant of livers from living relatives: selection of recipients and donors]. (2000) (0)
The Impact of Portal Flow Modulation (PFM) in the A2ALL Cohort Study.: Abstract# 613 (2014) (0)
Reply (2015) (0)
Impact of visceral adiposity on outcomes from hepatocellular carcinoma following liver transplantation (2016) (0)
Right vs Left: Progress but no Conclusion in Selecting Donors for Live Donor Liver Transplantation. (2022) (0)
Successful sequential liver and stem cell transplantation for primary alamyloidosis with hepatic failure (2001) (0)
[173] SYSTEMATIC APPLICATION OF CADAVER EXPANDED DONOR CRITERIA AND LIVING DONOR LIVER ALLOGRAFTS IMPROVE PATIENT ACCESS AND OUTCOMES (2007) (0)
Current treatments, determinants of use, and survival for patients with hepatoma in the United States from 1998-2002. (2006) (0)
Proposal for a Worldwide Usable Score for the Prediction of Recurrence and Intention-to-Treat Survival after Liver Transplantation in Patients with Hepatocellular Cancer (2018) (0)
Laparoscopic living donor right hepatectomy (2017) (0)
ECHINOCOCCAL PULMONARY HYPERTENSION TREATED WITH TARGETED PULMONARY VASCULAR THERAPY AND HEPATIC RESECTION (2006) (0)
217 Risk-Stratification of Heart Transplant (HTX) Candidates with Advanced Liver Dysfunction (2011) (0)
[Heterotopic or orthotopic liver replacement with liver segments?]. (1987) (0)
LIVER PRESERVATION WITH VASOSOL SOLUTION: A SINGLE CENTER COMPARISON WITH U.W. SOLUTION (2004) (0)
Rapid Growth in Small Liver Allografts Enables All Grafts to Reach 50% of Standard Liver Volume Within 14 Days.: Abstract# 1483 (2014) (0)
SHORT TERM RESULTS OF LIVING RELATED LIVER TRANSPLANTATION(招待講演VII ,第29回日本小児外科学会総会) (1993) (0)
Financial impact of liver transplant surgery (Reply) (1990) (0)
L/I‐7 Comparison of HCV outcomes in recipients of expanded‐criteria, living donor, and standard liver grafts (2006) (0)
EXPERIENCEWITH RADICAL RESECTION INTHE MANAGEMENT OFPROXIMAL BILEDUCTCANCER (1989) (0)
A SOLUTION FOR HEMODYNAMIC INSTABILITY THAT MINIMIZES BLOOD TRANSFUSION REQUIREMENT IN LIVER TRANSPLANTATION (1991) (0)
Liver transplantation in children : Advances in patient selection, technique and immunosuppression : Pediatric liver transplantation (1997) (0)
An intention-to-treat competing-risk model for candidates with hepatocellular cancer waiting for liver transplantation (2019) (0)
Dynamic Inflammatory Gene Expression Profiles Among Patients With and Without Acute Cellular Rejection (ACR) During the First Post-Transplant Year.: Abstract# D2345 (2014) (0)
Transplant vs Resection for Intrahepatic Cholangiocarcinoma - Potential for Benefit with Transplant? (2021) (0)
Improved Post-Liver Transplant Survival in MELD Era: Advanced Management or Better Selection?: Abstract# B1077 (2014) (0)
CA19-9 as an independent risk factor for survival in hepatocellular carcinoma. (2013) (0)
[Shunt surgery with reference to indications for liver transplantation]. (1989) (0)
EX VIVO RESECTION AND AUTOTRANSPLANTATION FOR LOCALLY INVASIVE TUMORS INVOLVING MAJOR VASCULAR PEDICLES: 3023 (2010) (0)
Serum adiponectin and overall survival in a prospective cohort of patients with hepatocellular carcinoma. (2012) (0)
Rule categories and their use in technical diagnosis (1986) (0)
Vibration Controlled Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation. (2023) (0)
Ex Vivo Liver Resection and Autotransplantation (2022) (0)
Remembrance of a Passing Pandemic (2021) (0)
T Cell and Myeloid Chimerism Without GVHD in Human Intestinal and Liver Transplantation: A Prospective Study.: Abstract# A3 (2014) (0)
34 SUCCESSFUL APPLICATION OF EMERGENCY AUXILIARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION IN A CHILD WITH FULMINANT HEPATIC FAILURE FROM AMANITA PHALLOIDES INGESTION. (1996) (0)
Appropriate prophylaxis for variceal bleeding and spontaneous bacterial peritonitis is underutilized in hospitalized patients with cirrhosis (2000) (0)
The effect of RAGE signaling on colorectal liver metastases (2006) (0)
Study of complex formation in aqueous solution. II: Computerized protometric method of determination of free ion concentrations in solution (CILS method) and estimation of complex stability constants. Application to the copper(II) complexes of N,N-dimethyl-1,2-diaminoethane (1986) (0)
Live Donor Liver Transplantation: An International Perspective. (2016) (0)
ELEVATED PREOPERATIVE NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS OUTCOME IN PATIENTS WITH HCC AFTER LIVER TRANSPLANTATION: 616 (2008) (0)
Chapter 72 – Postoperative Care of Pediatric Transplant Recipients (2015) (0)
1019 Liver Atrophy and Regeneration in Non-Cirrhotic Portal Vein Thrombosis: Effect of Surgical Shunts (2012) (0)
Should Portasystemic Shunts be Avoided in Potential Liver Transplant Candidates? (1990) (0)
Outcomes of Full-Right-Full Left Split Liver Transplantation in Adults in US: A Propensity-Score Matched Ananlysis. R. Saidi,1 M. Hertl,2 (2017) (0)
LBP-23-Prognostic Impact of Peritumoral Neutrophil Infiltration on Hepatocellular Carcinoma Recurrence Following Liver Transplantation (2019) (0)
L/I‐13 Donor hepatectomy morbidity based on the Clavien scale (2006) (0)
PGD Is Associated With Persistent Differential Gene Expression After Lung Transplantation (2015) (0)
Reply: To PMID 24954365. (2015) (0)
[Experience with liver transplantation at the University of Chicago]. (1987) (0)
287 The Effects of RAGE Signaling on the Development of Colorectal Liver Metastases (2010) (0)
Combined Therapy with an LHRH Agonist and an Antiandrogen in Prostatic Carcinoma (1984) (0)
Locoregional therapy for unresectable and recurrent intrahepatic cholangiocarcinoma (2021) (0)
VOLUME DETERMINATION OF NORMAL AND REGENERATING LIVER - COMPARISON OF CT AND MRI TECHNIQUES (1992) (0)
Maximal Androgen Blockage in Prostate Cancer: Today’s Therapy of Choice and 5-Year Clinical Experience (1990) (0)

This paper list is powered by the following services:

Other Resources About Jean Emond

en.wikipedia.org

What Schools Are Affiliated With Jean Emond?

Jean Emond is affiliated with the following schools:

Jean Emond's Academic­Influence.com Rankings